Search clinical trials for: intrinsic resistance NSCLC EGFR
Total 15654 results
-
First People's Hospital of HangzhouNot yet recruitingBrain Metastases | EGFR Positive Non-small Cell Lung CancerChina
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRecruitingNon Small Cell Lung Cancer | EGFR Activating Mutation | Stage III NSCLCChina
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.RecruitingLocally Advanced or Metastatic Epithelial TumorChina
-
University of Wisconsin, MadisonDoris Duke Charitable FoundationRecruitingMetastatic Colorectal CancerUnited States
-
Guangdong Association of Clinical TrialsRecruiting
-
Geneplus-Beijing Co. Ltd.Shanghai Chest HospitalRecruitingLung Neoplasms | Adenocarcinoma of Lung | Lung Cancer, Nonsmall Cell | Squamous Cell Lung CancerChina
-
Fudan UniversityRecruitingOropharyngeal CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruiting
-
Genprex, Inc.RecruitingCarcinoma, Non-Small Cell LungUnited States
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingChemotherapy | Surgery | Non Small Cell Lung Cancer | EGFR Activating Mutation | EGFR TKI
-
The First Affiliated Hospital of Guangzhou Medical...Not yet recruitingNon-Small Cell Lung Cancer Stage IIIAChina
-
Shanghai Chest HospitalRecruitingNon Small Cell Lung CancerChina
-
Tian XieLinkDoc Technology (Beijing) Co. Ltd.RecruitingAdenocarcinoma | Carcinoma | Non-Small-Cell Lung CancerChina
-
AstraZenecaRecruitingNon-Small Cell Lung CancerChina, United States, Chile, Vietnam, Thailand, Brazil, Bulgaria, Canada, Germany, India, Japan, Korea, Republic of, Poland, Russian Federation, Singapore, Turkey, Austria, Israel, Spain, Taiwan, Mexico, France, Italy, Peru, Switzerland, United...
-
Guangdong Association of Clinical TrialsNot yet recruitingDacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
University Hospital, ToulouseInstitut National de la Santé Et de la Recherche Médicale, France; National...RecruitingLung Cancer, Nonsmall CellFrance
-
Shanghai Chest HospitalRecruitingNon Small Cell Lung CancerChina
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingLung Cancer Non-small Cell Stage IV
-
PfizerRecruitingEGFR Mutation-positive Inoperable or Reccrent NSCLCJapan
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.RecruitingLocally Advanced or Metastatic NSCLCChina
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.RecruitingNon-small Cell Lung Cancer | ALK-Positive Lung CancerKorea, Republic of, Hong Kong, Malaysia, Singapore
-
Betta Pharmaceuticals Co., Ltd.RecruitingNon Small Cell Lung Cancer | Brain MetastasesChina
-
Centre Francois BaclesseGFPCRecruitingALK Gene Rearrangement Positive | NSCLC Stage IV | NSCLC Stage IIIB | EGFR Gene Mutation | ROS1 Gene MutationFrance
-
Cullinan Therapeutics Inc.RecruitingNon Small Cell Lung Cancer | EGFR Exon 20 MutationUnited States, Taiwan, Spain, Korea, Republic of, Japan, Singapore, Italy, Netherlands, Hong Kong
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingEGFR Positive Non-small Cell Lung CancerChina
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingNon-small Cell Lung CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingEGFR-mutant Non-Small Cell Lung CancerChina
-
AstraZenecaRecruitingCarcinoma, Non-Small-Cell LungUnited States, China, Korea, Republic of, Canada, Italy, Poland, Spain, Belgium, Netherlands, Japan, Germany, Brazil, Turkey, Russian Federation, United Kingdom, Greece, Israel, Australia, France, Puerto Rico
-
Shanghai EpimAb Biotherapeutics Co., Ltd.CovanceRecruitingNeoplasms | Neoplasm Metastasis | Non-Small-Cell Lung CancerUnited States, China
-
AstraZenecaHutchison MediPharmaRecruitingCarcinomaDenmark, Spain, United States, Taiwan, Vietnam, Canada, Korea, Republic of, Brazil, India, Japan, Italy, Puerto Rico, France, Chile
-
British Columbia Cancer AgencySunnybrook Health Sciences Centre; AstraZeneca; Princess Margaret Hospital, CanadaRecruitingBrain Metastases | Lung Cancer Non-small Cell Stage IVCanada
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHypoxia | Insulin Resistance | Obstructive Sleep ApneaUnited States
-
Dana-Farber Cancer InstituteAstraZenecaRecruiting
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingHead and Neck Cancer | Esophageal Cancer | Non-small Cell Lung Cancer | Other Metastatic Solid TumorsChina
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruiting
-
Merus N.V.Chiltern International Inc.; Q2 Solutions; Oncology Therapeutic Development (OTD) and other collaboratorsRecruitingGastric Cancer | Colorectal Cancer | NSCLC | Head and Neck Squamous Cell Carcinoma | HNSCC | Advanced/Metastatic Solid Tumors | Gastroesophageal-junction CancerUnited States, Spain, Belgium, France, Netherlands, United Kingdom
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingHead and Neck Cancer | Esophageal Cancer | Non-small Cell Lung Cancer | Other Metastatic Solid TumorsUnited States
-
Qilu Pharmaceutical Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Chinese... and other collaboratorsNot yet recruiting
-
PD Dr. med. Volker HeinemannMGO Ruhr-University Bochum (RUB)RecruitingColo-rectal Cancer | RAS Wild-type | UICC III | UICC II + RF | UICC IV Curative IntentGermany
-
Daiichi SankyoRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Japan, Netherlands, Taiwan
-
Apollomics Inc.RecruitingGastric Cancer | Pancreatic Cancer | NSCLC | Lung Cancer | Brain Tumor | Glioblastoma Multiforme | Advanced Cancer | Colon Cancer | Solid Tumors | Thyroid Cancer | Renal Cancer | Gastroesophageal Junction Adenocarcinoma | EGFR Gene Mutation | MET Amplification | HGF | MET Alteration | MET Fusion | Exon 14 SkippingUnited States, Spain, France, United Kingdom, Taiwan, Australia, Finland, Italy, Singapore, Hungary, Canada, Puerto Rico, Russian Federation
-
Novartis PharmaceuticalsRecruitingAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MelanomaSpain, Japan, Korea, Republic of, Taiwan, Netherlands, United States, Italy, Canada, Singapore
-
Novartis PharmaceuticalsRecruitingAdvanced Solid Tumors Which Are cMET-dependentGermany, Korea, Republic of, Belgium, Italy, Singapore, United States, Denmark, Spain, France, Canada
-
Shaare Zedek Medical CenterAstraZenecaRecruiting
-
Sun Yat-sen UniversityRecruitingEGFR Tyrosine Kinase Inhibitors Plus VEGFR InhibitorsChina
-
Beijing Haidian Hospital307 Hospital of PLA; Peking University People's Hospital; 309th Hospital of Chinese...RecruitingThe Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR MutationNon-small Cell Lung Cancer(NSCLC)China
-
Sun Yat-sen UniversityRecruitingLung Neoplasms | Bronchial Neoplasms | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung Cancer | Adenosquamous Cell Lung Cancer | Stage IB Non-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingCarcinoma, Non-Small Cell Lung | EGFR Gene MutationChina
-
Sun Yat-sen UniversityRecruitingNon-small Cell Lung Cancer (NSCLC) | EGFR-TKI Resistant Mutation | EGFR-TKI Sensitizing Mutation | Somatic Mutation | Germline MutationsChina